BIOFORCE NANOSCIENCES HOLDINGS, INC.
Close on Oct 19, 2026
- Market cap
- $230.52M
- P/E (TTM)
- 687.2
- Dividend yield
- –
About Bioforce Nanosciences
Laboratory Analytical Instruments, SIC 3826
BioForce Nanosciences Holdings, Inc. provides nutritional supplements, vitamins, minerals, powders, and beverages aimed at supporting active lifestyles across diverse age groups. Its primary offering is BioForce Eclipse, a private-label nutritional multivitamin and mineral powder containing amino acids, vitamins, and plant-based proteins formulated to promote physical well-being and muscle growth. The company distributes its products to active individuals, sports participants, and older adults through online retail, social media, direct marketing, and telemarketing channels.
The company operates within the United States, utilizing contract manufacturing and packaging services provided by a Virginia-based partner. Administrative, marketing, sales, and customer support operations are managed from an executive office in Virginia Beach, Virginia. BioForce holds no physical real estate of its own, conducting its business activities from shared office facilities.
Summary of the business section of Bioforce Nanosciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BIOFORCE NANOSCIENCES HOLDINGS, INC.
- Founded
- 2015
- Headquarters
- Virginia Beach, VA
- Address
- 2020 General Booth Blvd, Suite 230 23454
- Phone
- (757) 306-6090
- Website
- bioforceeclipse.com
- Employees
- 3, Dec 31, 2025
- Industry
- Laboratory Analytical Instruments
- Fiscal year ends
- December 31
- Auditor
- MICHAEL GILLESPIE & ASSOCIATES, PLLC, Vancouver, Washington
Stock & identifiers
- Ticker
- BFNH
- Exchange
- OTC
- Shares outstanding
- 34M, Aug 10, 2026
- Public float
- $2.63M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-5 reverse, Mar 4, 2020; 1-for-5 reverse, Feb 28, 2020
- SEC CIK
- 1310488
- CUSIP
- 09064C206
- ISIN
- US09064C2061
- EIN
- 85-2138858
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Richard Kaiser Kaiser | CEO & CFO, Director | 1,424,447 |
| Scott Mager | Director | 1,000,000 |
| Merle Ferguson | Director | 16,470,000 |
Employees
Headcount reported in annual reports
“The Company has three full time employees, Mr.”
Corporate history
Events identified from SEC filings